In short. Five questions before paying for a course of collagen biostimulators: what you want changed, whether you can wait, who injects, and what happens if it fails.

Key points

  • A careful clinician will say before the first session what a fair result looks like, when it will be judged, and what the plan is if the photographs at three months show no change.
  • A plan that cannot answer that has no stopping rule, and a course without one has no end.

A collagen biostimulator is not one appointment that produces one result. It is a short course of injections that asks your own tissue to lay down collagen over the months that follow, which makes starting one a decision about months rather than about an hour in a clinic. Five questions separate a considered decision from an impulse.

What, precisely, do you want to look different?

Not “fresher” and not “better”, but which area, and in what way. Biostimulators are used where the problem is tissue quality and diffuse volume loss: a face that reads as deflated or thin-skinned rather than one that has descended. If the honest answer is that your jawline has dropped, or that you dislike the shape of your nose, this is not the treatment that changes it.

Naming the area precisely matters for a second reason: it becomes the thing you judge later. A vague goal cannot be assessed in a photograph.

Can you wait two months for an answer?

The early fullness after a session is the carrier gel, and much of it goes within a fortnight. What you are buying is deposited gradually and is not visible for weeks. The stretch from about week three to week six decides whether a course finishes at all. If your reason for treatment is an event in three weeks, this is the wrong tool.

Ask what happens if it does not work

A careful clinician will say before the first session what a fair result looks like, when it will be judged, and what the plan is if the photographs at three months show no change. A plan that cannot answer that has no stopping rule, and a course without one has no end.

Who injects, and where does responsibility sit afterwards?

The person who injects should be the person who assessed you, who sets the intervals, and who is answerable at review. Ask what they would do if a firm lump appeared months later, and where. Because a biostimulator cannot be dissolved, that answer matters more here than with a filler.

What does the course cost you in time?

Count the visits, the travel and the waiting between them, then count the maintenance horizon afterwards. That whole picture is what you are agreeing to, and it is a different question from what one appointment costs.

Reasons to stop before you start

  • You want something visible within a fortnight, or reversible if you dislike it — neither is available here.
  • Your real concern is sagging, a double chin or a feature you would like reshaped — different questions with different answers.
  • You are being moved by a package, a deadline or a discount, and nobody has offered a stopping rule.

Answering the five questions honestly will sometimes end with not booking, and that is a good outcome rather than a lost one. For the reader whose answers line up — a specific area, a tolerance for waiting, a practitioner still there at review — a course is reasonable to begin.

Related reading

Frequently asked questions

What is the first thing I should be able to describe before booking?

The area you want changed, in words precise enough to find in a photograph. Not fresher or better, but a named region and a named change. If the honest answer is that a jawline has dropped or a feature should be reshaped, no course of biostimulator injections will produce it, and the assessment should say so before anything is booked.

Why does a course need a stopping rule agreed in advance?

Because the effect is gradual and cannot be dissolved, so there is no natural moment at which the treatment announces that it has finished. A stopping rule fixes in advance what a fair result looks like and what happens if the three-month photographs show no change. Without one, a course has no end except exhaustion.

Should the person who assesses me also be the one who injects?

Ideally yes, because the assessment sets the areas, the intervals and the technique, and the same clinician has to be answerable months later if a firm lump appears. If a different person injects, ask explicitly who holds responsibility for a delayed reaction, and where that would be assessed and managed.

Risks & Limitations

  • Nodules and granulomas — firm lumps or an inflammatory reaction that can appear weeks or months after treatment and may need assessment and treatment rather than simply resolving.
  • Irreversibility: a biostimulator cannot be dissolved. An uneven or unwanted result has to be managed over time, not switched off.
  • Infection or inflammation at the injection site.
  • Asymmetry or over-correction. Over-treatment in an area that cannot be dissolved is harder to correct than under-treatment.
  • Lumpiness or irregularity in the first weeks while the material settles, which usually resolves but occasionally does not.
  • Bruising, swelling, tenderness and occasional headache after treatment.
  • A biostimulator does not lift descended tissue and does not remove fat. The effect is gradual over months, it is not permanent, and maintenance treatment is required.

When to Seek Care

  • A firm, growing or painful lump at or near an injection site, appearing weeks or months after treatment — this needs assessment even when it is not painful.
  • Redness, warmth, swelling or pus at an injection site, or fever.
  • Skin breakdown, blistering, or a dusky or mottled patch over a treated area — seek care immediately.
  • Increasing pain, or pain out of proportion to the injection.
  • Difficulty breathing, facial swelling or a widespread rash — possible severe reaction; seek emergency care immediately.

References & Further Reading

  • American Academy of Dermatology (AAD) — injectable and skin safety information
  • American Society of Plastic Surgeons (ASPS) — injectable treatment guidance
  • U.S. Food and Drug Administration (FDA) — approved injectable products and safety communications
  • National Medical Products Administration (NMPA, China) — approved product status
  • Chongqing West District Hospital — Plastic Surgery & Aesthetics Medical Center

Medically reviewed by Ke He, MD (何锞), Deputy Director & Head of Skin & Laser Aesthetics. Last reviewed: 19 September 2026.

This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.